Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer

Name: Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer
Published: 2007
License: Public Domain

AstraZeneca · 2007

ClinicalTrials.gov · Datasets · License: Public Domain · 2007

Open Source ↗

ovarian neoplasm, advanced ovarian cancer, poly(adp ribose) polymerases, ku-0059436, azd2281, brca1 protein, brca2 protein, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer

Related documents